Article
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.
Leukemia - 1 Mar 2024
England James T, Szuber Natasha, Sirhan Shireen, Dunne Tom, Cerquozzi Sonia, Hill Madeleine, Villeneuve Pierre J A, Ho Jenny M, Sadikovic Bekim, Bhai Pratibha, Krishnan Nupur, Dowhanik Sebastian, Hillis Chris, Capo-Chichi Jose-Mario, Tsui Hubert, Cheung Verna, Gauthier Karine, Sibai Hassan, Davidson Marta B, Bankar Aniket, Kotchetkov Rouslan, Gupta Vikas, Maze Dawn
Abstract excerpt
Myeloproliferative neoplasms (MPNs) are a group of chronic hematologic malignancies that lead to morbidity and early mortality due to thrombotic complications and progression to acute leukemia. Clinical and mutational risk factors have been demonstrated to predict outcomes in patients with MPNs and are used commonly to guide therapeutic decisions, including allogenic stem cell transplant, in myelofibrosis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
